Editas Medicine EDIT
NASDAQ EDIT
$2.59 +0.08 (+3.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) EV to CFO (2017)

Updated

Editas Medicine's (EDIT) EV to CFO came in at 358.93 for Q3 2017.

Analysis

Editas Medicine (EDIT) EV to CFO (2017) Analysis & Trends

For the trailing twelve months through Sep 30, 2017, EV to CFO at Editas Medicine was -77.36.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Editas Medicine 234.09 Mn -477.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 358.93
Jun 30, 2017 28.02
Mar 31, 2017 19.10
API Access

Editas Medicine EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=EDIT&period=max&api_key=YOUR_API_KEY